News & Updates
Showing Endocrinology articles
Showing

Glycaemic control in early T2D improved with novel oral GLP-1 receptor agonist
For adults with early type 2 diabetes (T2D) not adequately controlled by diet and exercise alone, treatment with the investigational small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist orforglipron yields significant reductions in glycated haemoglobin levels, according to data from the phase III ACHIEVE-1 trial.

RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
A 12-month therapeutic intervention with self-administered abatacept can delay the onset of rheumatoid arthritis (RA) in at-risk individuals for up to 4 years, according to results from the ALTO follow-up study presented at EULAR 2025.

Ecnoglutide trims weight in adults with obesity
Once-a-week treatment with ecnoglutide demonstrates superiority over placebo, with sustained reductions in body weight and improvements in cardiometabolic indexes among adults with overweight or obesity, reports a study presented at ADA 2025.





